Ramani – Pulmonary Hypertension for the Pulmonologist
Maryland CC Project
00:00
Non-PAH Groups and Clinical Implications
Dr. Ramani summarizes groups 2–5, therapeutic implications, and risks of indiscriminate vasodilator use.
Play episode from 07:25
Transcript
